SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-007244
Filing Date
2023-03-10
Accepted
2023-03-10 16:16:37
Documents
12
Period of Report
2023-03-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 36621
  Complete submission text file 0001493152-23-007244.txt   205747

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE mslp-20230309.xsd EX-101.SCH 3248
3 XBRL LABEL FILE mslp-20230309_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE mslp-20230309_pre.xml EX-101.PRE 22373
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3297
Mailing Address 4721 IRONTON STREET DENVER CO 80239
Business Address 4721 IRONTON STREET DENVER CO 80239 (800) 210-7369
MusclePharm Corp (Filer) CIK: 0001415684 (see all company filings)

IRS No.: 770664193 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-53166 | Film No.: 23723837
SIC: 2834 Pharmaceutical Preparations